End-stage renal disease attributable to diabetes mellitus.
about
Prevalence of chronic kidney disease in population-based studies: systematic reviewSubclinical Hypothyroidism and Type 2 Diabetes: A Systematic Review and Meta-AnalysisIdentifying and slowing progressive chronic renal failureTight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study GroupEnd-stage renal disease in young black males in a black-white population: longitudinal analysis of the Bogalusa Heart Study.Nephropathy in type 2 diabetes.Comparison of diabetes control among Haitians, African Americans, and non-Hispanic whites in an urban safety-net hospital.Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study.Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid conditionCalcium antagonists in diabetic hypertension.Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes.Spatial distribution of end-stage renal disease (ESRD) and social inequalities in mixed urban and rural areas: a study in the Bretagne administrative region of France.Applying multiple interventions in chronic kidney disease.Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010.Racial/Ethnic Differences in Insulin Resistance and Beta Cell Function: Relationship to Racial Disparities in Type 2 Diabetes among African Americans versus Caucasians.A high-throughput method for measurement of glycohemoglobin in blood samples utilizing laser-accelerated proteolysis and MALDI-TOF MS.Influence of Socio-Economic Inequalities on Access to Renal Transplantation and Survival of Patients with End-Stage Renal DiseasePrevalence of chronic kidney disease in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysisManaging hypertension in diabetic patients--focus on trandolapril/verapamil combination.Cardiovascular risk factors in CKD associate with both ESRD and mortality.Review: Glycation of human serum albumin.The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements.Retinal proteome alterations in a mouse model of type 2 diabetes.Ideal cardiovascular health score and incident end-stage renal disease in a community-based longitudinal cohort study: the Kailuan Study.Glucose mediates transcriptional repression of the human angiotensin type-1 receptor gene: role for a novel cis-acting elementThe ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients.Social Determinants of Health and Racial/Ethnic Disparities in Type 2 Diabetes in Youth.Postoperative complications of total laryngectomy in diabetic patients.Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review.Prevalence of various comorbidities among veterans with chronic kidney disease and its comparison with other datasets.The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study Group.End-stage renal disease. Measures to prevent it or slow its progression.The role of diabetes mellitus and hypertension in chronic kidney disease.Fixed-dose combination antidiabetic therapy: real-world factors associated with prescribing choices and relationship with patient satisfaction and compliance.Evaluation of risk factors for development of complications in Type II diabetes in Europe.Pharmacokinetics of rosiglitazone in patients with end-stage renal disease.Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients.[Increase in prevalence of diabetes mellitus as a cause of dialytic end-stage renal disease: analysis of 20 years in the west region of Paraná].Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects.
P2860
Q21257215-44D5DD43-12FA-4D16-994B-5E2FBD950F75Q26798245-92042A0E-1DD1-4562-A362-E82E5D3F0F05Q28344781-20ED54EA-9DBE-430C-890F-E2A91F5BA4A8Q29617736-04B95AE9-EEF1-4180-87E1-A78FE6EE71D3Q30939425-90B2E41D-004C-43DB-A1BF-79A0A6BBB1B3Q33542374-E6CE4806-EB05-40D4-8BB9-6D54C866B75AQ33729311-949FA2D3-635B-4BF6-81B7-A42E1841DF22Q33950911-9B8FDCC8-B839-4C3C-9706-9F0D5C2BE03DQ34105962-630490B5-6DB4-4058-AACC-D66FE9ABA526Q34434724-5F5677E6-6B4A-4B02-A806-0EAFAE70DC34Q34453963-97DFA77C-F991-464B-9DB8-519E2356B6ADQ35026499-38BC8A20-A68C-4DE2-B9C9-B5FE10E46911Q35086974-8FD0CAE8-4587-4766-AA3F-C96FE2C4A47CQ35641817-0F4CF228-3EFE-40E2-8C8A-631AA83E25A3Q35857908-5CEF6E63-F26B-4DF7-9931-7B6AE9BEF8C9Q35872449-45797C62-92DF-4D7A-82D8-55D16CBADCCAQ35990919-B0347CE4-29A5-4B24-A405-8421F5616AF5Q36202909-7808B87B-32E0-490B-86F2-1C69C228190FQ36536275-D646FBD1-89CC-4624-A1ED-DE718A91D727Q36977343-A3ABED14-0DA3-4556-9802-7DC2A23D02A4Q37227387-922E725B-9841-4E27-8D71-B189EA204B0CQ37326570-79A42587-F761-43CA-A2C5-3080D2C45C6CQ37374086-8E2D7B6B-C0B5-4130-AE8D-D9E6DB97327EQ37516833-629CD467-FDA9-40F1-A1B4-5194339B2C6EQ37537905-101D7819-3CA9-43DC-9D92-45DA2207292DQ37605795-EC2B5D77-2B39-4412-888B-B32E9841B448Q37936466-C75EC5F1-D833-4FBE-B327-668210F0297FQ38664782-8B1E587F-0726-4243-9B55-845A74266BDCQ38901700-5FD358C5-12C8-40B2-817C-7F36955D9ACBQ39231126-783A8FB7-AD87-45C9-AD0C-140DA583F72CQ40208226-4A2704AD-F0CF-4E0A-8D74-DE93D40FC949Q40753379-6F905D4D-ADBB-4B2B-BFEC-F96DE01CB87CQ41210785-1EA96865-F651-456A-896B-8A6E4CB6BE8EQ43113872-2411AC9E-F0C1-4A7C-AE93-36109FFFA3B6Q43881274-D3531879-E8E7-43E5-8A38-65BFBF311531Q44075872-80B31508-CE0C-43D7-AF1D-19D6C4A18E9FQ44139569-3F04F9AE-92B4-4948-9911-470C53F04B07Q44520360-AB972443-CDB4-4C86-A2DE-B12FC37B7285Q44690129-EA8DD669-80E2-4254-AFEB-DD703B815D0CQ46473170-67B41DFC-33B6-407E-8C48-E6824696417B
P2860
End-stage renal disease attributable to diabetes mellitus.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
End-stage renal disease attributable to diabetes mellitus.
@en
End-stage renal disease attributable to diabetes mellitus.
@nl
type
label
End-stage renal disease attributable to diabetes mellitus.
@en
End-stage renal disease attributable to diabetes mellitus.
@nl
prefLabel
End-stage renal disease attributable to diabetes mellitus.
@en
End-stage renal disease attributable to diabetes mellitus.
@nl
P2093
P1476
End-stage renal disease attributable to diabetes mellitus.
@en
P2093
Brancati FL
Perneger TV
Whelton PK
P304
P356
10.7326/0003-4819-121-12-199412150-00002
P407
P577
1994-12-01T00:00:00Z